Search research articles
Contact Us
Filters
Showing results (351-360 of 551) with videos related to
Page
of 56
Sort By:
Vaccine
|
July 19, 2020
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine
Marcel E Curlin, Jason Shao, Gabriela Diaz, et al.
The New England Journal of Medicine
|
January 17, 2014
Helicase-primase inhibitor pritelivir for HSV-2 infection
Anna Wald, Lawrence Corey, Burkhard Timmler, et al.
Plos Medicine
|
December 6, 2021
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
Shelly Karuna, Shuying Sue Li, Shannon Grant, et al.
The Journal of Infectious Diseases
|
December 15, 2010
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons
Jared M Baeten, Jairam Lingappa, Ingrid Beck, et al.
Plos Pathogens
|
April 24, 2026
Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression
Tosin E Omole, Huong Mai Nguyen, Agata Marcinow, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
Nigel Garrett, Asa Tapley, Jessica Andriesen, et al.
The Journal of Infectious Diseases
|
February 3, 2006
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility
Huanliang Liu, Mary Carrington, Chunhui Wang, et al.
Elife
|
April 23, 2013
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
Joshua T Schiffer, David Swan, Ramzi Al Sallaq, et al.
Science Translational Medicine
|
February 5, 2016
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes
Joshua T Schiffer, David A Swan, Amalia Magaret, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
Colleen C McLaughlin, Margaret K Doll, Kathryn T Morrison, et al.
Page
of 56
Search research articles
Search
Showing results (351-360 of 551) with videos related to
Sort By:
Page
of 56
Vaccine
|
July 19, 2020
Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine
Marcel E Curlin, Jason Shao, Gabriela Diaz, et al.
The New England Journal of Medicine
|
January 17, 2014
Helicase-primase inhibitor pritelivir for HSV-2 infection
Anna Wald, Lawrence Corey, Burkhard Timmler, et al.
Plos Medicine
|
December 6, 2021
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study
Shelly Karuna, Shuying Sue Li, Shannon Grant, et al.
The Journal of Infectious Diseases
|
December 15, 2010
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons
Jared M Baeten, Jairam Lingappa, Ingrid Beck, et al.
Plos Pathogens
|
April 24, 2026
Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression
Tosin E Omole, Huong Mai Nguyen, Agata Marcinow, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
Nigel Garrett, Asa Tapley, Jessica Andriesen, et al.
The Journal of Infectious Diseases
|
February 3, 2006
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility
Huanliang Liu, Mary Carrington, Chunhui Wang, et al.
Elife
|
April 23, 2013
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract
Joshua T Schiffer, David Swan, Ramzi Al Sallaq, et al.
Science Translational Medicine
|
February 5, 2016
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes
Joshua T Schiffer, David A Swan, Amalia Magaret, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results
Colleen C McLaughlin, Margaret K Doll, Kathryn T Morrison, et al.
Page
of 56